Innovus Pharmaceuticals Overview
- Year Founded
-
2010
- Status
-
Acquired/Merged
- Employees
-
27
- Latest Deal Type
-
M&A
- Financing Rounds
-
6
- Investments
-
6
Innovus Pharmaceuticals General Information
Description
Developer of pharmaceutical products based in San Diego, California. The company is engaged in the commercialization, licensing and development of safe and effective non-prescription medicine and consumer care products to improve men's and women's health and vitality and respiratory diseases and distributes OTC medicines and consumer and health products directly, through commercial partners to primary care physicians, urologists, gynecologists and therapists, and directly to consumers.
Contact Information
Website
www.innovuspharma.comCorporate Office
- 5470 Kietzke Lane
- Suite 300
- Reno, NV 89511
- United States
Corporate Office
- 5470 Kietzke Lane
- Suite 300
- Reno, NV 89511
- United States
Innovus Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Innovus Pharmaceuticals Comparisons
Industry
Financing
Details
Innovus Pharmaceuticals Competitors (2)
One of Innovus Pharmaceuticals’s 2 competitors is Alvogen Group, a Formerly PE-Backed company based in Morristown, NJ.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Alvogen Group | Formerly PE-Backed | Morristown, NJ | ||||
| Mallinckrodt Pharmaceuticals | Formerly PE-Backed | Dublin, Ireland |
Innovus Pharmaceuticals Patents
Innovus Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-3122982-A1 | Oral compositions comprising cinnamaldehyde and uses thereof | Pending | 29-Dec-2020 | ||
| US-11696899-B2 | Oral compositions comprising cinnamaldehyde and uses thereof | Active | 29-Dec-2020 | ||
| US-20220202740-A1 | Oral compositions comprising cinnamaldehyde and uses thereof | Active | 29-Dec-2020 | ||
| CA-3084207-A1 | Compositions and methods for treating urinary conditions | Pending | 27-Feb-2020 | ||
| US-20210268057-A1 | Compositions and methods for treating urinary conditions | Inactive | 27-Feb-2020 | A61K36/54 |
Innovus Pharmaceuticals Signals
Innovus Pharmaceuticals Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Innovus Pharmaceuticals Investments & Acquisitions (6)
Innovus Pharmaceuticals’s most recent deal was a Merger/Acquisition with Prime Savings Club. The deal was made on 01-Apr-2019.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Prime Savings Club | 01-Apr-2019 | Merger/Acquisition | Media and Information Services (B2B) | ||
| Supplement Hunt | 14-Dec-2018 | Merger/Acquisition | Internet Retail | ||
| Boston Topicals (4 Branded Topical Products) | 19-Nov-2018 | Corporate | Buildings and Property | ||
| Beyond Human | 01-Mar-2016 | Merger/Acquisition | Personal Products | ||
| Zestra | 30-Dec-2013 | Merger/Acquisition | Personal Products |
Innovus Pharmaceuticals Affiliates
Subsidiaries (2)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Supplement Hunt | Las Vegas, NV | 2015 | |
| Zestra | New York, NY | 1996 |
Innovus Pharmaceuticals FAQs
-
When was Innovus Pharmaceuticals founded?
Innovus Pharmaceuticals was founded in 2010.
-
Where is Innovus Pharmaceuticals headquartered?
Innovus Pharmaceuticals is headquartered in Reno, NV.
-
What is the size of Innovus Pharmaceuticals?
Innovus Pharmaceuticals has 27 total employees.
-
What industry is Innovus Pharmaceuticals in?
Innovus Pharmaceuticals’s primary industry is Other Consumer Non-Durables.
-
Is Innovus Pharmaceuticals a private or public company?
Innovus Pharmaceuticals is a Private company.
-
What is Innovus Pharmaceuticals’s current revenue?
The current revenue for Innovus Pharmaceuticals is .
-
How much funding has Innovus Pharmaceuticals raised over time?
Innovus Pharmaceuticals has raised $3.93M.
-
Who are Innovus Pharmaceuticals’s investors?
Canterbury Capital (South Carolina), North Horizon, and Roxiticus Ventures have invested in Innovus Pharmaceuticals.
-
Who are Innovus Pharmaceuticals’s competitors?
Alvogen Group and Mallinckrodt Pharmaceuticals are competitors of Innovus Pharmaceuticals.
-
When was Innovus Pharmaceuticals acquired?
Innovus Pharmaceuticals was acquired on 06-Aug-2024.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process